Arcutis Will get FDA Nod For Plaque Psoriasis Cream
This text has been revised and corrected from the unique model. Westlake Village-based immune-dermatology firm Arcutis Biotherapeutics Inc. has acquired federal approval to start advertising and marketing its drug to deal with plaque psoriasis in youngsters ages 6 to 11. The corporate had already acquired approval to market the drug to be used in individuals 12 … [Read more…]